Work to create these first specifications was done in direct collaboration with ISPE and GS1 global technical experts, and is the foundation for the forthcoming PSS 2.0, which will address nine exchange use cases between Level 3 (site serialization manager) and Level 2 (line serialization controllers and smart devices). PSS 2.0 is targeted for release…
TraceLink Expands Operations to Meet the Growing Serialization Movement
Watchdog Group: Medicaid’s Child Psychotropic Drugging Needs Greater Oversight
The mental health watchdog Citizens Commission on Human Rights (CCHR) applauded the recent Department of Justice health care fraud crackdown but says greater oversight is needed of Medicaid billing of psychotropic drugs prescribed children, which could reduce their use and increase protections. In announcing a national health care fraud takedown by the U.S. Department of Justice (DOJ)…
Pharma Execs See End-to-End Product Visibility Achievable in Five Years
NEXUS 17 attendees cite information sharing as largest benefit from end-to-end visibility. TraceLink Inc., a global track and trace network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, announced new industry findings from its annual conference, NEXUS 17. Interactive polling results indicated that the majority of pharmaceutical supply…
FDA to Delay Enforcement of DSCSA Product Identifier Requirements
TraceLink to Fully Manage DSCSA Administrative Tasks for Hospitals and Pharmacies
Deadlines Loom in the March to Become Fully Compliant
The tracking systems resulting from DSCSA will complement the drug design control process, which includes guidelines that companies must follow in order to enter ingredients into the supply chain. The Drug Supply Chain Security Act (DSCSA) was first signed in to law four years ago. It “outlines critical steps to build an electronic, interoperable system…
Antares Vision Moving Headquarters to Larger NJ Facility
Antares Vision, provider of serialization-based track and trace solutions for the pharmaceutical industry, is moving its headquarters to a larger facility in Moorestown, New Jersey in early 2017. The upsized space will help Antares Vision increase capacity of ready-to-deploy serialization modules to help customers meet looming regulatory deadlines. Though full implementation of 2013’s Drug Supply Chain Security…